What is ICD-10 code C69.11?

C69.11 is the ICD-10-CM diagnosis code for Malignant neoplasm of right cornea. Cancer of the cornea, the clear front part of the right eye. It belongs to the ICD-10-CM chapter for neoplasms (c00-d49). C69.11 is a billable code, meaning it can be reported on a claim as a primary or secondary diagnosis when supported by documentation. C69.11 is part of the FY2026 ICD-10-CM code set published by the CMS National Center for Health Statistics and used on Medicare, Medicaid, and commercial claims in the United States.

Yes. C69.11 is a billable ICD-10-CM code that can be reported on professional and institutional claims as a primary or secondary diagnosis when the provider documentation supports the specific condition described. Billable codes in ICD-10-CM are coded to the highest level of specificity available for the documented diagnosis. C69.11 is current for fiscal year 2026 and remains in the active CMS ICD-10-CM code set published by the National Center for Health Statistics.

What is the V28 vs V24 difference for C69.11?

CMS phased in the V28 risk adjustment model over payment years 2024 (33%), 2025 (67%), and 2026 (100%), replacing V24. V28 consolidates HCC categories, removes some lower-acuity conditions, and recalibrates RAF weights across the entire model. For C69.11, V28 maps to Prostate, Breast, and Other Cancers and Tumors at RAF 0.186 while V24 mapped to Breast, Prostate, and Other Cancers and Tumors at RAF 0.150. Both models can still appear in legacy data and in payer-specific lookback periods.

What should coders know when reporting C69.11?

The fifth character specifies laterality; ensure right eye is clearly documented Corneal cancer is rare; obtain detailed ophthalmology reports with histological confirmation Because C69.11 maps to a payment HCC, the documentation must also satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's risk adjustment score.

2026 ICD-10-CM C69.11: Malignant neoplasm of right

ICD-10-CM Code View

HCC Buddy Code Card

Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.

Code lookupC69.11Effective periodFY2026 Apr Update (Apr 1-Sep 30)

FY 2026 Apr update / Neoplasms (C00-D49) / Malignant neoplasms of eye, brain and other parts of central nervous system (C69-C72)

C69.11

Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidance

Malignant neoplasm of right cornea

Cancer of the cornea, the clear front part of the right eye.

Buddy Insight

Right corneal malignancy is an extremely rare primary cancer that almost always represents squamous cell carcinoma or ocular surface squamous neoplasia with corneal invasion.

CMS-HCC V28

Mapped

HCC 23

Prostate, Breast, and Other C...

RAF 0.186

CMS-HCC V24

Mapped

HCC 12

Breast, Prostate, and Other C...

RAF 0.150

ACA/HHS

Mapped

HCC 12

HHS-HCC 12

Varies by metal level

ESRD/PACE

Mapped

HCC 12

Breast, Prostate, and Other C...

RAF 0.045

RXHCC

Mapped

HCC 22

Cancer, Other Specified Sites

RAF 0.124

Code Book Path

Official

C69Malignant neoplasm of eye and adnexa

C69.1Malignant neoplasm of cornea

C69.11Malignant neoplasm of right cornea

Inclusion Terms

Official

ICD-10-CM does not list inclusion terms for C69.11 in this effective period.

Excludes 2

Official

ICD-10-CM does not list Excludes 2 notes for C69.11 in this effective period.

Related Child Codes

Official

C69.10Malignant neoplasm of unspecified cornea

C69.12Malignant neoplasm of left cornea

Includes

Official

ICD-10-CM does not list Includes notes for C69.11 in this effective period.

Excludes 1

Official

ICD-10-CM does not list Excludes 1 notes for C69.11 in this effective period.

Code First

Official

ICD-10-CM does not list Code First sequencing instructions for C69.11 in this effective period.

Use Additional

Official

ICD-10-CM does not list Use Additional Code instructions for C69.11 in this effective period.

Code Also

Official

ICD-10-CM does not list Code Also instructions for C69.11 in this effective period.

Buddy Documentation Tip

HCC Buddy guidance

Pathology confirming primary corneal malignancy with histological type

Clear documentation of right eye involvement

Depth of corneal involvement (epithelial only versus stromal invasion)

Ophthalmologic examination including slit-lamp findings

MEAT Support

HCC Buddy guidance

Pathology confirming primary corneal malignancy with histological type

Clear documentation of right eye involvement

Depth of corneal involvement (epithelial only versus stromal invasion)

Ophthalmologic examination including slit-lamp findings

Audit Caution

HCC Buddy guidance

Coding conjunctival squamous cell carcinoma with corneal extension as primary corneal cancer

Laterality errors — particularly when reading from imaging reports with reversed orientation

Using unspecified code when right eye is clearly documented in the record

Common Mistakes

HCC Buddy guidance

C69.12 — Left cornea: verify laterality from clinical documentation

C69.01 — Right conjunctiva: if the tumor originates in the conjunctiva with corneal extension, code the conjunctival primary

C69.10 — Unspecified cornea: use C69.11 when right eye is documented

H18.49 — Corneal degeneration: do not confuse benign corneal changes with malignancy

Current with CMS: FY2026 ICD-10-CM Apr 1 update (effective Apr 1 – Sep 30, 2026) · CMS-HCC V28, 100% phased in for payment year 2026. FY2027 code set already staged for October 1, 2026. How HCC Buddy stays current →

Is C69.11 an HCC code?

Yes. C69.11 (Malignant neoplasm of right cornea) maps to Prostate, Breast, and Other Cancers and Tumors under the CMS-HCC V28 risk adjustment model (and Breast, Prostate, and Other Cancers and Tumors under V24), with a community non-dual aged RAF of 0.186. It is billable for payment year 2026.

Coder answer: C69.11 is billable and maps to V28 HCC 23, Prostate, Breast, and Other Cancers and Tumors. Open it in the Code Book for the tabular path, RAF, and MEAT checklist.

Code: C69.11
Description: Malignant neoplasm of right cornea
HCC (V28): HCC 23 — Prostate, Breast, and Other Cancers and Tumors
RAF: 0.186
Billable: Yes
Payment year: 2026

HCC Category Mapping

V28HCC 23, Prostate, Breast, and Other Cancers and Tumors

0.186

V24HCC 12, Breast, Prostate, and Other Cancers and Tumors

0.150

ESRDHCC 12, Breast, Prostate, and Other Cancers and Tumors

0.045

RxHCCHCC 22, Cancer, Other Specified Sites

0.124

Each model's RAF is its CMS base weight for that model's standard population, so weights are not directly comparable across models: CMS-HCC V28 and V24 use Community, Non-Dual, Aged; ESRD uses the dialysis continuing-enrollee model; RxHCC is the Part D continuing-enrollee, non-low-income, aged weight (a larger scale than CMS-HCC). ACA/HHS has no single weight — it varies by metal level. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.

Work C69.11 in the Code Book — tabular path, V28 RAF, and MEAT checklist →

MEAT Criteria for C69.11

For C69.11 to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically, it has to be re-documented and supported each calendar year.

MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
EEvaluate: test results, medication response, or physical findings reviewed by the provider
AAssess: explicit mention in the assessment or plan with acknowledgment of status
TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis

Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed C69.11 during that encounter, not just copy-forwarded from a problem list.

Coder workflow notes

Get the V28 RAF + MEAT cheat sheet

One printable page: confirm a code's V28 HCC status, its RAF weight, and the MEAT your note needs to make it stick. Free, no card.

Free PDF. No card. Unsubscribe anytime.

What This Code Means

C69.11 is the ICD-10-CM diagnosis code for malignant neoplasm of right cornea. Cancer of the cornea, the clear front part of the right eye. C69.11 sits in the ICD-10-CM chapter for neoplasms (c00-d49), within the section covering malignant neoplasms of eye, brain and other parts of central nervous system (c69-c72).

Under the CMS-HCC V28 risk adjustment model, C69.11 maps to Prostate, Breast, and Other Cancers and Tumors (HCC 23) with a community, non-dual, aged base RAF weight of 0.186. Under the older CMS-HCC V24 model, C69.11 maps to Breast, Prostate, and Other Cancers and Tumors (HCC 12) with a community, non-dual, aged base RAF weight of 0.150. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.

The fifth character specifies laterality; ensure right eye is clearly documented. Because C69.11 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.

HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for C69.11 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.

Coding Tips

•The fifth character specifies laterality; ensure right eye is clearly documented
•Corneal cancer is rare; obtain detailed ophthalmology reports with histological confirmation

Clinical Significance

Right corneal malignancy is an extremely rare primary cancer that almost always represents squamous cell carcinoma or ocular surface squamous neoplasia with corneal invasion. Proper laterality coding is essential for surgical planning, as treatment may include topical chemotherapy, excision, or even enucleation in advanced cases.

Documentation Requirements

✓Pathology confirming primary corneal malignancy with histological type
✓Clear documentation of right eye involvement
✓Depth of corneal involvement (epithelial only versus stromal invasion)
✓Ophthalmologic examination including slit-lamp findings
✓Distinction from limbal or conjunctival origin with corneal extension

Commonly Confused Codes

•C69.12: Left cornea: verify laterality from clinical documentation
•C69.01: Right conjunctiva: if the tumor originates in the conjunctiva with corneal extension, code the conjunctival primary
•C69.10: Unspecified cornea: use C69.11 when right eye is documented
•H18.49: Corneal degeneration: do not confuse benign corneal changes with malignancy